chereb19
13 minutes ago
Vivos, Inc. has renewed its Executive Employment Agreement with CEO Dr. Michael Korenko, effective January 1, 2024, for two more years. Korenko will earn a $295,500 annual salary, receive 20,000 shares of restricted stock, be eligible for up to $40,000 in annual bonuses based on performance, and get
abeta
39 minutes ago
5,000,000
On October 31, 2024, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Convertible Note (the “Loan Agreement”) with an unrelated shareholder (the “Holder”) in the amount of $5,000,000. The Loan Agreement has a maturity of 24 months and no payments are due until